|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,165.00 JPY | +2.75% |
|
+2.84% | -22.38% |
| 04-13 | Cosmos Pharmaceutical's Nine-Month Profit Rises 1.8% | MT |
| 04-13 | Cosmos Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.75% | +2.84% | +5.75% | -6.14% | -22.38% | -31.77% | -14.23% | -27.94% | +22.81% | 2.94B | |
| +0.15% | +1.34% | +3.79% | -19.15% | -30.54% | -10.80% | -8.26% | -23.00% | -20.30% | 5.6B | |
| +0.36% | -1.43% | +10.61% | -9.27% | -16.09% | -5.24% | +49.66% | +5.53% | +65.35% | 3.45B | |
| +0.40% | +0.40% | +4.96% | -2.93% | -11.59% | -13.60% | -10.55% | +3.87% | -18.91% | 2.74B | |
| -0.79% | -1.72% | +3.18% | -5.46% | -24.48% | -1.15% | +31.22% | +23.96% | - | 2.09B | |
| +1.09% | +0.46% | +1.88% | 0.00% | -2.54% | +2.52% | -7.66% | -2.98% | +11.43% | 1.29B | |
| -1.39% | -3.72% | -6.57% | -14.56% | -23.11% | -45.94% | -51.26% | -64.96% | -42.03% | 1.27B | |
| -0.71% | +0.14% | +8.57% | +17.22% | +16.17% | +26.45% | +59.21% | +53.25% | +40.30% | 485M | |
| +0.27% | -1.20% | +5.56% | -8.64% | -20.94% | -43.89% | -66.59% | +8.80% | +350.92% | 349M | |
| -2.08% | -2.89% | -15.76% | -20.59% | -27.22% | -26.08% | -31.56% | +3.41% | -37.52% | 309M | |
| +0.74% | -3.39% | -4.87% | -17.19% | -25.10% | -28.75% | -35.13% | -33.21% | +16.62% | 194M | |
| Average | +0.07% | -1.10% | +1.56% | -7.88% | -17.08% | -16.20% | -7.74% | -4.84% | +38.87% | 1.88B | |
| Weighted average by Cap. | +0.41% | -0.46% | +4.31% | -9.63% | -20.30% | -13.66% | +1.62% | -9.36% | +11.92% |
- Stock Market
- Stocks
- 3349 Stock
- Sector COSMOS Pharmaceutical Corporation
Select your edition
All financial news and data tailored to specific country editions
